Brief: Radiopharm Theranostics Posts HY Net Loss Attributable A$12.6 Million
Feb 28 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* HY NET LOSS ATTRIBUTABLE A$12.6 MILLION
Source text for Eikon: ID:nASX2NN7vY
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsNASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:50 AM